Private Equity Firms in Delhi: Top Firms in 2026

Key Facts: Delhi NCR Private Equity at a Glance

• As of January 2026, 379 active private equity and venture capital investors operate across the Delhi NCR ecosystem. This makes it one of India's two dominant PE hubs alongside Mumbai.
• Caisse de dépôt et placement du Québec (CDPQ) leads all active investors by portfolio count, with 192 investments recorded in the Delhi NCR ecosystem.
• ChrysCapital and Quadria Capital each manage USD 4B+ in assets under management from their New Delhi headquarters, making them the two largest Delhi-domiciled PE funds.
• Everstone Capital, headquartered in Singapore with offices in New Delhi and Gurugram, manages USD 5B+ across private equity, infrastructure, and venture capital strategies.
• Late-stage investment activity across India has attracted USD 265B across 1,615 rounds over the past five years, reflecting institutional appetite at scale.
• Delhi NCR's PE ecosystem concentrates domestic mid-market fund managers, while Mumbai houses most international mega-fund India offices. Several firms maintain dual-city presences to cover pan-India deal flow.
• Core sectors attracting Delhi-based PE capital include healthcare, financial services, consumer and retail, IT services, and technology-enabled businesses.

Private Equity Firms in Delhi NCR India: Market Overview

The Delhi NCR ecosystem sits at the center of India's domestic private equity industry. New Delhi serves as the primary headquarters base for India-founded fund managers, including ChrysCapital, CX Partners, Kedaara Capital, Samara Capital, Quadria Capital, and Madison India Capital. Gurugram and Noida function as satellite hubs within the region, with Everstone Capital maintaining offices across both New Delhi and Gurugram.

This geography creates a clear division of labor within Indian PE. International mega-funds, including Blackstone, KKR, Carlyle, Bain Capital, and Warburg Pincus, locate their India offices predominantly in Mumbai. Delhi NCR is where domestic fund managers were built and where mid-market deal origination is strongest. Several firms, including Kedaara Capital and ChrysCapital, maintain both Delhi and Mumbai presences to reflect pan-India investment mandates rather than geographic restriction.

India's GDP growth, the Make in India and Digital India initiatives, and SEBI's Alternative Investment Fund (AIF) regulatory framework have collectively enabled fund formation at scale. Category II AIFs cover unlisted equity strategies, providing the legal backbone for most PE funds operating from the region. Delhi NCR fund managers operate within a broader Indian ecosystem that has deployed USD 1.02 trillion across 17,186 rounds. Seed-stage activity produced USD 2.87B across 1,314 rounds, while early-stage rounds accounted for USD 52.8B across 1,962 rounds in the past five years.

Healthcare, financial services, consumer, and IT services dominate sectoral allocation for Delhi-based fund managers. These sectors cluster here partly because Delhi NCR hosts many of India's largest non-Mumbai corporate headquarters. The region's mid-market economy also generates the deal flow that domestic growth equity and buyout funds require.

Firm Comparison at a Glance

The table below covers the major private equity and institutional investors operating from Delhi NCR, sorted by confirmed AUM where available. AUM figures are omitted for firms where data is not publicly confirmed.

The table illustrates a clear strategic split. General Atlantic and Baring PE bring international capital and global networks. ChrysCapital and Quadria represent the highest-AUM domestic institutional managers. Samara Capital occupies the control-oriented mid-market buyout space, while CX Partners, Kedaara, and Madison India serve founders at different stages of the growth curve.

Top Picks by Investment Strategy

Largest AUM in Delhi NCR: Everstone Capital (USD 5B+) manages the largest pool of capital among Delhi NCR-based PE firms, deploying across PE, infrastructure, and VC strategies in both India and Southeast Asia.

Dominant Healthcare Investor: Quadria Capital (USD 4B+) is Asia's leading healthcare-dedicated PE firm, with three deals closed between 2023 and 2024 alone: NephroPlus (Asia's largest dialysis network with 435+ centers), Maxivision Eye Care, and Straits Orthopaedics.

Growth Equity Leader: General Atlantic, managing USD 118B globally from its New York headquarters, maintains a dedicated Delhi office. The firm has backed Reliance Jio Platforms, Reliance Retail, and BillDesk in India, demonstrating mega-cap growth conviction at a scale few funds can match.

Strongest Mid-Market Buyout Track Record: Samara Capital built its reputation on majority control transactions, supporting MBOs, MBIs, and management-led divestments. Its 2023 exit from Lotus Surgicals and its 2024 Agro Tech Foods transformation into Sundrop Brands demonstrate disciplined execution across the buy-own-sell cycle.

Premier Domestic Fund: ChrysCapital has operated continuously since 1999, closing eight funds and deploying capital across healthcare, financial services, consumer, and IT. Its USD 850M Fund VIII closed in 2019, and its exit from Intas Pharmaceuticals produced more than USD 1B, one of the largest PE exits in Indian history.

Institutional Portfolio Count Leader: CDPQ has recorded 192 investments in the Delhi NCR ecosystem, the highest portfolio count of any active investor in the region.

Most Active Pan-Asian Operator: Baring Private Equity Asia (USD 20B+ AUM) brings pan-Asian geographic reach through its Delhi office, positioning portfolio companies for growth across multiple Asian markets rather than India alone.

Best for Minority Growth Capital: Madison India Capital takes explicit minority positions with board-level strategic participation, making it the most relevant option for founders who need institutional backing without relinquishing majority ownership.

Top Firms in Detail

ChrysCapital

The benchmark for domestic Indian PE, ChrysCapital has deployed capital continuously since 1999, longer than any other India-founded fund manager of comparable scale. Its USD 4B+ AUM spans eight successive funds, with Fund VIII closing at USD 850M in January 2019. The firm targets high-quality companies in sectors with strong return-on-capital profiles, prioritizing cash-on-cash returns over headline IRR metrics. Portfolio anchors include Mankind Pharma, Hero FinCorp, and Infogain, spanning pharmaceuticals, financial services, and IT services respectively. The defining proof point is the Intas Pharmaceuticals exit, which generated over USD 1B, one of the largest realizations in Indian PE history. ChrysCapital suits founders in established, profitable businesses seeking a long-term institutional partner with a 25-year exit track record.

Quadria Capital

Quadria Capital is the only pure-play healthcare PE fund at institutional scale in South and Southeast Asia. The firm has built a USD 4B+ AUM platform concentrated entirely in diagnostics, hospitals, medical devices, and pharmaceuticals. Its investment approach treats healthcare delivery as an industrial challenge: Quadria provides operational expertise alongside capital, partnering with management teams to build scalable platforms across eight markets. The 2024 NephroPlus investment backed Asia's largest dialysis network, with over 435 centers across India, the Philippines, Uzbekistan, and Nepal. The 2023 Maxivision and Straits Orthopaedics deals extend the same model into ophthalmology and orthopaedics. Founders building healthcare delivery, diagnostic, or medtech businesses in South Asia will find Quadria the most operationally focused capital partner by sector depth and deployment pace.

Everstone Capital

Everstone Capital connects Delhi NCR founders to India and Southeast Asian capital networks through its Singapore headquarters and offices in New Delhi and Gurugram. The firm manages USD 5B+ across private equity, infrastructure, and venture capital. It operates with a control orientation and a geographic mandate spanning the Indian subcontinent and Southeast Asia. Its consumer thesis is proven: Burger King India and Modern Foods both entered Everstone's portfolio as mid-market platforms scaled through operational intervention. The fund's multi-strategy structure also provides co-investment optionality across asset classes, a feature institutional limited partners find attractive. Founders building consumer, healthcare, logistics, or industrial businesses with regional expansion ambitions represent Everstone's core target.

General Atlantic

General Atlantic manages more than USD 100B in AUM and maintains a dedicated Delhi office, bringing international LP relationships and a global operational network spanning 29 locations. The firm has applied a growth equity philosophy since 1980 and has demonstrated India conviction through investments in Reliance Jio Platforms, Reliance Retail, and BillDesk. These transactions required capital scale and institutional credibility to participate in deals involving India's largest corporate groups. The firm's dedicated Climate strategy adds ESG-aligned capital for founders in sustainability-adjacent sectors. General Atlantic suits high-growth companies in technology, financial services, and consumer sectors that need a partner capable of deploying at scale with global go-to-market networks.

Samara Capital

Samara Capital's defining characteristic is its preference for majority ownership. Since 2007, the firm has deployed over USD 2B across management buyouts, buy-ins, and controlled divestments spanning consumer, healthcare, financial services, and business services. Its investment criteria are explicit: businesses ranked among the top three in their sector or category, with an exceptional management team, operating in markets shifting from unorganized to organized. The November 2024 acquisition of Del Monte Foods through its Agro Tech Foods platform, forming the combined Sundrop Brands entity, demonstrates buy-and-build capability at scale. The 2023 exit from Lotus Surgicals via a full controlling stake sale confirms its capacity to realize value cleanly. Samara is the most relevant Delhi NCR partner for founder-led businesses where ownership transition or corporate divestment is the transaction trigger.

CX Partners

CX Partners is a boutique growth equity investor operating from New Delhi, targeting mid-market opportunities at the Series B to late-stage range. Its sectoral focus spans financial services, consumer, healthcare, and IT, with tickets starting at USD 20M+. The investment philosophy centers on backing product and service companies led by entrepreneurial management teams with market leadership potential. Its portfolio of 27 investments reflects consistent execution within a focused mandate. The firm's principals bring deep Indian institutional PE experience and understand the operational and governance challenges specific to Indian mid-market companies. Founders scaling past established revenue milestones who need a Delhi-based partner with sector-specific judgment at the Series B stage represent CX Partners' target profile.

Kedaara Capital

Kedaara Capital occupies an unusual position in Delhi NCR PE. It operates as an operations-based fund formed in explicit partnership with CD&R (Clayton Dubilier & Rice), one of the world's most recognized operational value creation firms in global private equity. This partnership gives Kedaara access to CD&R's industrial playbook for improving businesses post-investment, not merely providing capital and board seats. The firm targets companies with market leadership positions and sound management, deploying tickets of USD 20M+ across financial services, consumer, healthcare, and IT. Its dual New Delhi and Mumbai presence reflects a pan-India mandate. Founders in categories with clear leadership potential who want a fund manager that treats operational improvement as a core competency will find Kedaara a differentiated option among Delhi NCR buyout and growth equity firms.

Baring Private Equity Asia

Baring Private Equity Asia brings USD 20B+ in AUM and a pan-Asian platform built since 1997 to its Delhi office. The firm operates across growth equity and buyout strategies, with a geographic scope covering India, Southeast Asia, China, and broader Asian markets. Portfolio companies backed by Baring PE gain access to cross-border networks, management benchmarks from Asian peers, and regional expansion pathways that India-only fund managers cannot offer. This reach is its primary differentiator from domestic Delhi NCR investors. Ticket sizes in India run from USD 20M to USD 75M, placing the firm squarely in the mid-to-upper mid-market. Founders building businesses with regional Asian growth ambitions, or LPs seeking Asia-wide PE exposure through a single platform, will find Baring PE the most globally connected option in the Delhi NCR universe.

CDPQ

The most active investor in the Delhi NCR ecosystem by raw portfolio count, CDPQ has recorded 192 investments in the region, nearly double the count of the next most active institutional investor. As Canada's largest pension fund manager, CDPQ brings permanent institutional capital with a long-duration investment horizon. This stands in contrast to the fund-cycle pressure that characterizes most PE firms. Its multi-stage investment approach and global AUM provide co-investment capacity at scale. CDPQ is most relevant to businesses where capital continuity and patient holding periods create more value than quick-turn exits. LPs building diversified alternatives portfolios with India exposure will see CDPQ's Delhi NCR activity as a signal of long-term institutional conviction in the region's growth trajectory.

Madison India Capital

Madison India Capital's defining discipline is restraint. The firm takes explicit minority positions, contributing strategic perspectives and board-level participation without seeking majority control. Its portfolio of 27 investments spans consumer, healthcare, financial services, business services, and technology. This minority-first mandate makes Madison India one of the few Delhi-connected investors that categorically avoids the control dynamics characterizing buyout-oriented funds. The firm provides industry networks and strategic planning support as its primary value-add beyond capital, positioning it as a governance partner rather than an operational one. Founders who have built businesses to maturity and want an institutional board partner without triggering an ownership transition will find Madison India Capital among the most structurally compatible options in this market.

Investment Trends and Capital Flows

Healthcare Services Consolidation

Diagnostics, hospital networks, medical devices, and pharmaceuticals are attracting a disproportionate share of PE capital relative to sector size. Quadria Capital alone closed three transactions between 2023 and 2024, backing NephroPlus, Maxivision, and Straits Orthopaedics across dialysis, ophthalmology, and orthopaedics. India's healthcare delivery market remains structurally underpenetrated, with provider consolidation creating large addressable platforms for PE-backed build-up strategies.

Financial Services Expansion and Fintech

Financial services and fintech represent the single largest sectoral concentration across Delhi NCR fund mandates. This sector appears in the investment focus of ChrysCapital, CX Partners, Kedaara Capital, Samara Capital, and General Atlantic simultaneously. ChrysCapital's position in Hero FinCorp and General Atlantic's investment in BillDesk illustrate the breadth of the opportunity, from non-bank lenders to digital payments infrastructure. Formalization of credit access and insurance penetration continues to expand the addressable market for PE-backed financial services companies.

Unorganized-to-Organized Sector Shift

Consumer and retail sector consolidation has become the defining operational thesis for mid-market PE in India. Samara Capital's transformation of Agro Tech Foods into Sundrop Brands through the Del Monte Foods acquisition in November 2024 illustrates how PE capital accelerates branded product rollups in previously fragmented categories. Everstone Capital's Burger King India and Modern Foods investments reflect the same thesis applied to food services and branded goods. India's rising middle class and growing preference for branded consumption over unbranded alternatives sustain the demand side of this trend.

ESG and Impact Investing

ESG considerations have moved from voluntary disclosure to explicit investment criteria at leading Delhi NCR firms. Quadria Capital frames its healthcare portfolio around 500M+ lives touched; General Atlantic has built a dedicated Climate strategy as a distinct investment vertical. Samara Capital's stated mandate includes positive impact for all stakeholders alongside financial returns. This shift reflects LP pressure from institutional investors globally who require ESG reporting as a fund governance standard, not merely a marketing point.

Digital India and Technology Adoption

Government-driven digitization has expanded the addressable market for technology-enabled businesses across sectors. The Digital India initiative has accelerated adoption of IT services, fintech platforms, and tech-enabled consumer companies, all areas where Delhi NCR fund managers are active. ChrysCapital's investment in Infogain reflects the technology services thesis alongside its broader sector-agnostic mandate. Early-stage capital has tracked this trend, with USD 52.8B deployed across 1,962 early-stage rounds in India over the past five years.

How to Evaluate PE Investors in This Market

Track record is the starting point for any due diligence process. Cash-on-cash returns and exit multiples across past funds reveal more than internal rate of return alone, since IRR is sensitive to holding period manipulation. ChrysCapital's USD 1B+ exit from Intas Pharmaceuticals provides a concrete external reference point; Samara Capital's clean exit from Lotus Surgicals in 2023 offers another. Firms with multiple realized exits across market cycles carry meaningfully lower risk than those relying on one landmark deal to establish credibility.

Sector expertise should match your business, not just your sector label. Quadria Capital's depth in healthcare delivery is specific enough that founders in general consumer healthcare may fit better with ChrysCapital or Samara Capital. Evaluate whether a fund manager has invested in companies at your exact stage and size, not simply in your industry vertical. CX Partners and Kedaara Capital focus explicitly on companies with market leadership potential, which means businesses still establishing category position may not align with their investment thesis.

Fund structure and remaining uncommitted capital, sometimes called dry powder, matters for timing. A fund manager in the final deployment phase of an aging vintage faces different return pressure than one in the first two years of a new fund. Understanding a firm's current fund vintage and deployment timeline helps assess whether their incentive structure aligns with your holding period needs. Assess value-add specificity: Kedaara Capital's CD&R partnership provides identifiable operational methodology, while General Atlantic's global network is verifiable through named portfolio introductions. Treat generic claims of "value-add" with no demonstrable mechanism as a yellow flag during due diligence.

Which Firm Fits Your Needs?

Founders seeking growth equity with a minority structure and a USD 20M+ ticket should start with CX Partners, Kedaara Capital, or General Atlantic. CX Partners and Kedaara both operate from Delhi NCR with sector-specific expertise and mid-market mandates; General Atlantic offers global network access alongside capital for companies that have already demonstrated category leadership.

Founders navigating an ownership transition, whether a management buyout, corporate divestment, or partner exit, will find Samara Capital the most structurally relevant option in the region. Samara's explicit majority ownership model and MBO/MBI track record means it is built for exactly this scenario. Healthcare founders specifically should open conversations with Quadria Capital, whose USD 4B+ AUM is deployed exclusively in diagnostics, hospitals, and medical devices across South and Southeast Asia.

Limited partners and institutional allocators building India-focused alternatives exposure should note CDPQ's 192-investment portfolio as a signal of depth. Everstone Capital's multi-strategy structure across PE, infrastructure, and VC provides diversification within a single manager relationship. LPs seeking global firms with verified India conviction should assess Baring Private Equity Asia and General Atlantic, both of which maintain Delhi offices as active deal origination posts rather than symbolic regional presences.

Methodology

This guide to private equity firms in Delhi NCR India was compiled using publicly available firm data, portfolio disclosures, and fund announcements current as of early 2026. Firm counts and investment round data draw from PE market tracking sources with a reference date of January 4, 2026, covering the Delhi NCR ecosystem. AUM figures reflect the most recently published information for each firm. Firms were selected based on headquarters or active office presence in Delhi NCR, confirmed investment activity in India, and availability of sufficient public data to support substantive editorial description. Deal examples and exit cases reference publicly announced transactions. Firms for which no reliable data could be confirmed are excluded rather than estimated.